Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
One of the most frequent complications of diabetic retinopathy is diabetic macular edema. Recently, intravitreal bevacizumab and intravitreal triamcinolone were the most popular therapeutic modalities. However, as the long term effects of intravitreal bevacizumab and intravitreal triamcinolone on visual acuity and macular thickness have not been compared, it was the purpose of the present study to compare these treatment effects
Epistemonikos ID: 7bee6ae3a74be06ba575a17808c1aba0b2f1b1d1
First added on: May 06, 2024